How many insider declarations has Walters Group filed?

Walters Group has filed 2 public insider declarations with SEC (Form 4).

What is Walters Group's role?

Walters Group's reported role is not specified by the regulator across the filings.

Which companies does Walters Group report trades for?

Walters Group reports trades for Zentalis Pharmaceuticals, Inc..

What is Walters Group's declared buy vs sell volume?

Across the available history, declared buys total 19.7M€ and disposals 0.

← Executives ★ Sign in to follow

WG

Walters Group

OWNER 10PCTM

·SEC (Form 4)

Zentalis Pharmaceuticals, Inc.

0

Total declarations

0

Company

€20m

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+18.2%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the full record of transactions filed by Walters Group. Officer active across 1 company, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 2 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €19.7m. Activity tracked since 31 December 2025. The latest transaction was filed on 14 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Walters Group

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Zentalis Pharmaceuticals, Inc. (US)

Declarations2 total

▲

WALTERS GROUP

10% OwnerExecutives14 Aug 2026Zentalis Pharmaceuticals, Inc.

$15M40SEC ↗

4,335,000 shares@ US$3.504.25% mcap66.6% of flowCommon StockSEC:0001213900-26-091823:0

Canonical exit: 12 Nov 2026 (T+90)

▲